Does abbreviated dual antiplatelet therapy after PCI provide a clinically meaningful trade-off between bleeding and ischaemic events in patients at high risk for bleeding?
Giovanna LiuzzoCarlo PatronoPublished in: European heart journal (2021)
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- atrial fibrillation
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- acute myocardial infarction
- prognostic factors
- heart failure
- st elevation myocardial infarction
- coronary artery bypass grafting
- left ventricular